Novavax is part of the FDA’s COVID-19 booster debate, but its vaccine still hasn’t been authorized
admin Novavax’s NVAX, +1.04% COVID-19 vaccine candidate played a front-and-center role during this week’s debate about…
Read MorePharmaceuticals
Elmo gets the COVID vaccine, and says ‘there was a little pinch, but it was OK’
Meet “Vaccinate Me Elmo.” The little red Sesame Street character revealed on Twitter on Tuesday…
Read MoreFDA advisers say the U.S. needs updated COVID-19 boosters to fight omicron
The U.S. should pursue a COVID-19 booster strategy that focuses on developing new shots that…
Read MoreBed Bath & Beyond, GoPro, Nike are stocks to watch
SAN FRANCISCO (MarketWatch) — Among the companies whose shares are expected to see active trade…
Read MoreGoogle, Barnes & Noble are stocks to watch Wednesday
An earlier version of this story included companies that are scheduled to report earnings on…
Read More